Keywords: abbott, buys, rights, aventis, tranolapril, health, care

Abbott buys rights to Aventis' tranolapril

Article | 14 June 2004

Print This

US health care major Abbott Laboratories is to acquire the remaining commercial (except in Japan) and global manufacturing rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in